STRAPC Stock Financial Analysis - Strategic Partners A/S (BATS-CHIXE) Stock

Overview

Orphazyme A/S is a biopharmaceutical company based in Denmark, primarily engaged in the development of novel therapies for the treatment of neurodegenerative orphan diseases. The company focuses on leveraging its technology platforms in Heat Shock Proteins (HSP) to develop and commercialize novel therapeutics for diseases caused by protein misfolding and aggregation, and lysosomal dysfunction, including amyotrophic lateral sclerosis (ALS) and Niemann-Pick disease Type C (NPC). A key project includes Arimoclomol, which is designed to amplify the production of HSPs in order to correct cellular dysfunction. Despite showing promise in clinical trials, Orphazyme faced significant setbacks, notably with the U.S. FDA rejecting its application for Arimoclomol for the treatment of NPC in 2021. This resulted in a strategic reevaluation to focus resources on advancing other pipeline projects and seeking strategic partners.

Quality, Value, Momentum Scores

This card shows the Quality, Value, and Momentum scores for the company

Quality

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Value

Proprietary scoring model that ranks companies based on their relative valuation. Scores range from 0 to 100, with 100 being the most undervalued.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Fund Sentiment

The Fund Sentiment (fka Ownership) score is a proprietary quantitative model that ranks companies based on levels of ownership accumulation.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Income Statement: Revenue, Operating Income, Net Income

The operating income for Strategic Partners A/S as of 31 December 2024 is -0.20 MM.
The net income for Strategic Partners A/S as of 31 December 2024 is -0.30 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2024-12-31		-0.20	-0.30
2024-09-30		0.82	-5.86
2024-06-30		1.84	-11.42
2024-03-31		-5.52	-18.73
2023-12-31		-12.88	-26.05
2023-06-30		-26.78	-40.70
2023-03-31		-34.01	-2.81
2022-12-31		-41.24	35.07
2022-06-30		-53.42	-99.78
2022-03-31		-68.45	-363.16
2021-12-31		-83.47	-626.54
2021-09-30	11.52	-324.24	-736.08
2021-06-30		-420.32	-845.61
2021-03-31		-514.43	-739.43
2020-12-31		-608.53	-633.25
2020-09-30		-512.49	-529.12
2020-06-30
2020-03-31

Income Statement: EPS

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2024-12-31
2024-09-30
2024-06-30	-323.16	-323.16
2024-03-31	-530.37	-530.37
2023-12-31	-738.00
2023-06-30	-1,149.58	-1,148.99
2023-03-31	-79.57	-78.98
2022-12-31	995.00	995.00
2022-06-30	-2,842.78	-2,842.78
2022-03-31	-10,372.37	-10,372.37
2021-12-31	-17,940.00
2021-09-30	-21,642.90	-21,642.90
2021-06-30	-25,551.79	-25,551.79
2021-03-31	-24,062.11	-24,062.11
2020-12-31	-22,324.12
2020-09-30	-20,698.86	-20,698.86
2020-06-30	-18,672.47	-18,672.47
2020-03-31	-17,821.27	-17,821.27

Cash Flow: Operations, Investing, Financing

The cash from operating activities for Strategic Partners A/S as of 31 December 2024 is -3.36 MM.
The cash from investing activities for Strategic Partners A/S as of 31 December 2024 is -9.33 MM.
The cash from financing activities for Strategic Partners A/S as of 31 December 2024 is 5.31 MM.

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2024-12-31	-3.36	-9.33	5.31
2024-09-30	-5.77	-6.64	2.31
2024-06-30	-8.19	-3.95	-0.69
2024-03-31	-14.10	-5.45	-0.69
2023-12-31	-20.02	-6.94	-0.69
2023-06-30	-13.60	90.35	-40.39
2023-03-31	-65.77	90.35	-37.73
2022-12-31	-117.94	90.35	-35.08
2022-06-30	-721.63	0.05	-23.85
2022-03-31	-662.10	0.05	-27.10
2021-12-31	-602.57	0.05	-30.34
2021-09-30	-275.29	-1.24	224.65
2021-06-30	-332.32	-3.34	465.29
2021-03-31	-435.70	-4.22	812.36
2020-12-31	-539.08	-5.10	1,159.42
2020-09-30	-451.73	-4.46	956.18
2020-06-30
2020-03-31

Valuation Metrics : PE, PriceToBook, PriceToTBV

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-06-30
2023-03-31
2022-12-31
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31

Valuation Metrics : EBitToEv, EBit3YrAvgToEv

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-06-30
2023-03-31
2022-12-31
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31

Management Effectiveness

The roa for Strategic Partners A/S as of 31 December 2024 is -0.59.
The roe for Strategic Partners A/S as of 31 December 2024 is -0.02.
The roic for Strategic Partners A/S as of 31 December 2024 is -0.71.
The croic for Strategic Partners A/S as of 31 December 2024 is -0.80.
The ocroic for Strategic Partners A/S as of 31 December 2024 is -0.51.

Period End (TTM)	ROA	ROE	ROIC	CROIC	OCROIC
2024-12-31	-0.59	-0.02	-0.71	-0.80	-0.51
2024-09-30	-0.30	-0.41	-0.30	-0.52	-0.30
2024-06-30	-0.52	-0.65	-1.16	-1.26	-0.88
2024-03-31	-0.45	-0.63	-1.83	-1.94	-1.41
2023-12-31	-0.86	-1.19	-3.49	-1.35	-0.95
2023-06-30	-0.53	-0.64	-1.72	-0.66	-0.47
2023-03-31	-0.13	-0.15	-0.41	-1.37	-2.28
2022-12-31	-0.58	-10.68	-2.39	-6.83	-17.32
2022-06-30	-0.23	-0.60	-0.84	-2.41	-6.11
2022-03-31	-0.85	-2.18	-3.07	-3.85	-5.60
2021-12-31	-0.76	-1.01	-12.71	-12.67	-12.22
2021-09-30	-0.89	-1.19	-14.93	-9.14	-13.38
2021-06-30	-1.25	-1.67	-3.75	-1.23	-3.18
2021-03-31	-1.09	-1.46	-3.28	0.73	-2.79
2020-12-31	-3.50	-11.96	-0.92	0.87	-0.78
2020-09-30	-2.93	-9.99	-0.77	0.71	-0.65
2020-06-30	-1.52	-1.89	-0.72	0.66	-0.62
2020-03-31	-1.37	-1.70	-0.65	0.10	-0.59

Gross Margins

Gross Margin: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Net Margin: The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.

Operating Margin: The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.

Period End (TTM)	Gross Margin	Net Margin	Operating Margin
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-06-30
2023-03-31
2022-12-31	1.00	-2.76	-15.38
2022-06-30	1.00	-2.76	-15.38
2022-03-31	1.00	-10.03	-15.80
2021-12-31	1.00	-17.31	-16.21
2021-09-30	1.00	-29.83	-27.67
2021-06-30	1.00	-64.30	-59.22
2021-03-31	1.00	-112.44	-105.49
2020-12-31
2020-09-30
2020-06-30
2020-03-31

DK:STRAP	DKK1,000.00
US:OZYMF
GB:0CUM
DE:1TB0